NEW YORK (GenomeWeb News) – As it awaits completion of its $3.7 billion buy of Gen-Probe, Hologic reported after the close of the market on Monday that its diagnostics business segment grew 11 percent year over year in its fiscal third quarter.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.
At Nature, John Wilbanks and Eric Topol call for openness in health data.
Law.com predicts that genomic and genetic testing will become common in toxic tort cases.
A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.